O	0	1	[	[	(	O
O	1	8	Altered	Alter	VBN	B-VP
O	9	19	expression	expression	NN	B-NP
O	20	22	of	of	IN	B-PP
O	23	27	PTEN	PTEN	NN	B-NP
O	28	32	gene	gene	NN	I-NP
O	33	36	and	and	CC	O
O	37	40	LOH	LOH	NN	B-NP
O	41	43	of	of	IN	B-PP
O	44	47	its	its	PRP$	B-NP
O	48	58	epigenetic	epigenetic	JJ	I-NP
O	59	73	microsatellite	microsatellite	NN	I-NP
O	74	76	in	in	IN	B-PP
B-Cancer	77	84	gastric	gastric	JJ	B-NP
I-Cancer	85	94	carcinoma	carcinoma	NN	I-NP
O	94	95	]	]	)	O
O	95	96	.	.	.	O

O	98	107	OBJECTIVE	OBJECTIVE	NN	B-NP
O	107	108	:	:	:	O
O	109	111	To	To	TO	B-VP
O	112	123	investigate	investigate	VB	I-VP
O	124	127	the	the	DT	B-NP
O	128	138	expression	expression	NN	I-NP
O	139	141	of	of	IN	B-PP
O	142	146	PTEN	PTEN	NN	B-NP
O	147	150	and	and	CC	I-NP
O	151	155	loss	loss	NN	I-NP
O	156	158	of	of	IN	B-PP
O	159	173	heterozygosity	heterozygosity	NN	B-NP
O	174	175	(	(	(	O
O	175	178	LOH	LOH	NN	B-NP
O	178	179	)	)	)	O
O	180	182	of	of	IN	B-PP
O	183	186	its	its	PRP$	B-NP
O	187	197	epigenetic	epigenetic	JJ	I-NP
O	198	212	microsatellite	microsatellite	NN	I-NP
O	213	215	in	in	IN	B-PP
B-Cancer	216	223	gastric	gastric	JJ	B-NP
I-Cancer	224	233	carcinoma	carcinoma	NN	I-NP
O	234	237	and	and	CC	O
O	238	245	explore	explore	VB	B-VP
O	246	251	their	their	PRP$	B-NP
O	252	257	roles	role	NNS	I-NP
O	258	260	in	in	IN	B-PP
O	261	272	progression	progression	NN	B-NP
O	273	275	of	of	IN	B-PP
B-Cancer	276	283	gastric	gastric	JJ	B-NP
I-Cancer	284	293	carcinoma	carcinoma	NN	I-NP
O	293	294	.	.	.	O

O	295	302	METHODS	METHODS	NNS	B-NP
O	302	303	:	:	:	O
O	304	307	LOH	LOH	NN	B-NP
O	308	310	of	of	IN	B-PP
O	311	321	epigenetic	epigenetic	JJ	B-NP
O	322	337	microsatellites	microsatellite	NNS	I-NP
O	338	340	of	of	IN	B-PP
O	341	345	PTEN	PTEN	NN	B-NP
O	346	347	(	(	(	O
O	347	354	D10S541	D10S541	NN	B-NP
O	354	355	,	,	,	O
O	356	363	D10S583	D10S583	NN	B-NP
O	364	367	and	and	CC	O
O	368	376	D10S1687	D10S1687	NN	B-NP
O	376	377	)	)	)	O
O	378	380	in	in	IN	B-PP
O	381	389	advanced	advance	VBN	B-NP
B-Cancer	390	397	gastric	gastric	JJ	I-NP
I-Cancer	398	404	cancer	cancer	NN	I-NP
O	405	408	was	be	VBD	B-VP
O	409	417	detected	detect	VBN	I-VP
O	418	420	by	by	IN	B-PP
O	421	424	PCR	PCR	NN	B-NP
O	424	425	-	-	HYPH	B-NP
O	425	429	SSCP	SSCP	NN	I-NP
O	429	430	.	.	.	O

O	431	441	Expression	Expression	NN	B-NP
O	442	444	of	of	IN	B-PP
O	445	449	PTEN	PTEN	NN	B-NP
O	450	454	mRNA	mRNA	NN	I-NP
O	455	458	and	and	CC	I-NP
O	459	466	protein	protein	NN	I-NP
O	467	469	in	in	IN	B-PP
O	470	476	normal	normal	JJ	B-NP
B-Multi-tissue_structure	477	484	gastric	gastric	JJ	I-NP
I-Multi-tissue_structure	485	491	mucosa	mucosa	NN	I-NP
O	492	495	and	and	CC	O
B-Cancer	496	503	gastric	gastric	JJ	B-NP
I-Cancer	504	510	cancer	cancer	NN	I-NP
O	511	514	was	be	VBD	B-VP
O	515	524	evaluated	evaluate	VBN	I-VP
O	525	527	by	by	IN	B-PP
O	528	530	RT	RT	NN	B-NP
O	530	531	-	-	HYPH	B-NP
O	531	534	PCR	PCR	NN	I-NP
O	535	538	and	and	CC	I-NP
O	539	543	SABC	SABC	NN	I-NP
O	544	564	immunohistochemistry	immunohistochemistry	NN	I-NP
O	564	565	,	,	,	O
O	566	578	respectively	respectively	RB	B-ADVP
O	578	579	.	.	.	O

O	580	583	The	The	DT	B-NP
O	584	596	relationship	relationship	NN	I-NP
O	597	604	between	between	IN	B-PP
O	605	615	expression	expression	NN	B-NP
O	616	618	of	of	IN	B-PP
O	619	623	PTEN	PTEN	NN	B-NP
O	624	628	mRNA	mRNA	NN	I-NP
O	629	632	and	and	CC	O
O	633	640	protein	protein	NN	B-NP
O	641	644	and	and	CC	I-NP
B-Multi-tissue_structure	645	650	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	651	655	node	node	NN	I-NP
O	656	666	metastasis	metastasis	NN	I-NP
O	667	669	or	or	CC	I-NP
O	670	673	LOH	LOH	NN	I-NP
O	674	676	of	of	IN	B-PP
O	677	692	microsatellites	microsatellite	NNS	B-NP
O	693	696	was	be	VBD	B-VP
O	697	706	discussed	discuss	VBN	I-VP
O	706	707	.	.	.	O

O	708	715	RESULTS	RESULTS	NNS	B-NP
O	715	716	:	:	:	O
O	717	720	LOH	LOH	NN	B-NP
O	721	723	of	of	IN	B-PP
O	724	731	D10S541	D10S541	NN	B-NP
O	731	732	,	,	,	I-NP
O	733	740	D10S583	D10S583	NN	I-NP
O	741	744	and	and	CC	I-NP
O	745	753	D10S1687	D10S1687	NN	I-NP
O	754	757	was	be	VBD	B-VP
O	758	763	found	find	VBN	I-VP
O	764	766	in	in	IN	B-PP
O	767	769	37	37	CD	B-NP
O	769	770	.	.	.	O
O	770	771	5	5	CD	B-NP
O	771	772	%	%	NN	I-NP
O	773	774	(	(	(	O
O	774	776	21	21	CD	B-NP
O	776	777	/	/	SYM	O
O	777	779	56	56	CD	B-NP
O	779	780	)	)	)	O
O	781	783	of	of	IN	B-PP
O	784	792	advanced	advance	VBN	B-NP
B-Cancer	793	800	gastric	gastric	JJ	I-NP
I-Cancer	801	808	cancers	cancer	NNS	I-NP
O	808	809	.	.	.	O

O	810	813	The	The	DT	B-NP
O	814	822	positive	positive	JJ	I-NP
O	823	828	rates	rate	NNS	I-NP
O	829	831	of	of	IN	B-PP
O	832	836	PTEN	PTEN	NN	B-NP
O	837	841	mRNA	mRNA	NN	I-NP
O	842	852	expression	expression	NN	I-NP
O	853	857	were	be	VBD	B-VP
O	858	860	80	80	CD	B-NP
O	860	861	.	.	.	O
O	861	862	4	4	CD	B-NP
O	862	863	%	%	NN	I-NP
O	864	865	(	(	(	O
O	865	867	45	45	CD	B-NP
O	867	868	/	/	SYM	O
O	868	870	56	56	CD	B-NP
O	870	871	)	)	)	O
O	871	872	,	,	,	O
O	873	875	45	45	CD	B-NP
O	875	876	.	.	.	O
O	876	877	5	5	CD	B-NP
O	877	878	%	%	NN	I-NP
O	879	880	(	(	(	O
O	880	881	5	5	CD	B-NP
O	881	882	/	/	SYM	I-NP
O	882	884	11	11	CD	I-NP
O	884	885	)	)	)	O
O	886	889	and	and	CC	O
O	890	892	32	32	CD	B-NP
O	892	893	.	.	.	O
O	893	894	1	1	CD	B-NP
O	894	895	%	%	NN	I-NP
O	896	897	(	(	(	O
O	897	899	18	18	CD	B-NP
O	899	900	/	/	SYM	B-NP
O	900	902	56	56	CD	I-NP
O	902	903	)	)	)	O
O	904	906	in	in	IN	B-PP
O	907	913	normal	normal	JJ	B-NP
B-Multi-tissue_structure	914	920	mucosa	mucosa	NN	I-NP
O	920	921	,	,	,	O
O	922	927	early	early	JJ	B-NP
O	928	931	and	and	CC	I-NP
O	932	940	advanced	advanced	JJ	I-NP
B-Cancer	941	948	gastric	gastric	JJ	I-NP
I-Cancer	949	959	carcinomas	carcinoma	NNS	I-NP
O	959	960	,	,	,	O
O	961	973	respectively	respectively	RB	B-ADVP
O	973	974	,	,	,	O
O	975	980	while	while	IN	B-SBAR
O	981	983	78	78	CD	B-NP
O	983	984	.	.	.	O
O	984	985	6	6	CD	B-NP
O	985	986	%	%	NN	I-NP
O	987	988	(	(	(	O
O	988	990	44	44	CD	B-NP
O	990	991	/	/	SYM	O
O	991	993	56	56	CD	B-NP
O	993	994	)	)	)	O
O	994	995	,	,	,	O
O	996	998	44	44	CD	B-NP
O	998	999	.	.	.	O
O	999	1000	5	5	CD	B-NP
O	1000	1001	%	%	NN	I-NP
O	1002	1003	(	(	(	O
O	1003	1004	5	5	CD	B-NP
O	1004	1005	/	/	SYM	I-NP
O	1005	1007	11	11	CD	I-NP
O	1007	1008	)	)	)	O
O	1009	1012	and	and	CC	O
O	1013	1015	28	28	CD	B-NP
O	1015	1016	.	.	.	O
O	1016	1017	6	6	CD	B-NP
O	1017	1018	%	%	NN	I-NP
O	1019	1020	(	(	(	O
O	1020	1022	16	16	CD	B-NP
O	1022	1023	/	/	SYM	I-NP
O	1023	1025	56	56	CD	I-NP
O	1025	1026	)	)	)	O
O	1027	1029	at	at	IN	B-PP
O	1030	1033	the	the	DT	B-NP
O	1034	1041	protein	protein	NN	I-NP
O	1042	1047	level	level	NN	I-NP
O	1047	1048	.	.	.	O

O	1049	1053	PTEN	PTEN	NN	B-NP
O	1054	1058	mRNA	mRNA	NN	I-NP
O	1059	1062	and	and	CC	I-NP
O	1063	1070	protein	protein	NN	I-NP
O	1071	1075	were	be	VBD	B-VP
O	1076	1080	less	less	RBR	I-VP
O	1081	1091	frequently	frequently	RB	I-VP
O	1092	1101	expressed	express	VBN	I-VP
O	1102	1104	in	in	IN	B-PP
O	1105	1110	early	early	JJ	B-NP
O	1111	1114	and	and	CC	I-NP
O	1115	1123	advanced	advanced	JJ	I-NP
B-Cancer	1124	1131	gastric	gastric	JJ	I-NP
I-Cancer	1132	1142	carcinomas	carcinoma	NNS	I-NP
O	1143	1147	than	than	IN	B-PP
O	1148	1152	that	that	DT	B-NP
O	1153	1155	in	in	IN	B-PP
O	1156	1162	normal	normal	JJ	B-NP
B-Multi-tissue_structure	1163	1170	gastric	gastric	JJ	I-NP
I-Multi-tissue_structure	1171	1177	mucosa	mucosa	NN	I-NP
O	1178	1179	(	(	(	O
O	1179	1180	P	P	NN	B-NP
O	1181	1182	<	<	SYM	B-ADJP
O	1183	1184	0	0	CD	B-NP
O	1184	1185	.	.	.	I-NP
O	1185	1187	05	05	CD	I-NP
O	1187	1188	)	)	)	O
O	1188	1189	.	.	.	O

O	1190	1195	There	There	EX	B-NP
O	1196	1199	was	be	VBD	B-VP
O	1200	1208	positive	positive	JJ	B-NP
O	1209	1220	correlation	correlation	NN	I-NP
O	1221	1228	between	between	IN	B-PP
O	1229	1233	PTEN	PTEN	NN	B-NP
O	1234	1238	mRNA	mRNA	NN	I-NP
O	1239	1249	expression	expression	NN	I-NP
O	1250	1253	and	and	CC	O
O	1254	1257	LOH	LOH	NN	B-NP
O	1258	1260	of	of	IN	B-PP
O	1261	1276	microsatellites	microsatellite	NNS	B-NP
O	1277	1279	in	in	IN	B-PP
O	1280	1288	advanced	advance	VBN	B-NP
B-Cancer	1289	1296	gastric	gastric	JJ	I-NP
I-Cancer	1297	1307	carcinomas	carcinoma	NNS	I-NP
O	1307	1308	.	.	.	O

O	1309	1313	PTEN	PTEN	NN	B-NP
O	1314	1321	protein	protein	NN	I-NP
O	1322	1332	expression	expression	NN	I-NP
O	1333	1343	paralleled	parallel	VBD	B-VP
O	1344	1348	with	with	IN	B-PP
O	1349	1352	its	its	PRP$	B-NP
O	1353	1357	mRNA	mRNA	NN	I-NP
O	1358	1368	expression	expression	NN	I-NP
O	1369	1370	(	(	(	O
O	1370	1371	P	P	NN	B-NP
O	1372	1373	<	<	SYM	B-ADJP
O	1374	1375	0	0	CD	B-NP
O	1375	1376	.	.	.	I-NP
O	1376	1378	05	05	CD	I-NP
O	1378	1379	)	)	)	O
O	1379	1380	.	.	.	O

O	1381	1384	The	The	DT	B-NP
O	1385	1395	expression	expression	NN	I-NP
O	1396	1398	of	of	IN	B-PP
O	1399	1403	PTEN	PTEN	NN	B-NP
O	1404	1408	mRNA	mRNA	NN	I-NP
O	1409	1412	and	and	CC	I-NP
O	1413	1420	protein	protein	NN	I-NP
O	1421	1424	was	be	VBD	B-VP
O	1425	1435	negatively	negatively	RB	I-VP
O	1436	1446	correlated	correlate	VBN	I-VP
O	1447	1451	with	with	IN	B-PP
B-Multi-tissue_structure	1452	1457	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1458	1462	node	node	NN	I-NP
O	1463	1473	metastasis	metastasis	NN	I-NP
O	1474	1476	of	of	IN	B-PP
O	1477	1485	advanced	advance	VBN	B-NP
B-Cancer	1486	1493	gastric	gastric	JJ	I-NP
I-Cancer	1494	1504	carcinomas	carcinoma	NNS	I-NP
O	1505	1506	(	(	(	O
O	1506	1507	P	P	NN	B-NP
O	1508	1509	<	<	SYM	B-ADJP
O	1510	1511	0	0	CD	B-NP
O	1511	1512	.	.	.	I-NP
O	1512	1514	05	05	CD	I-NP
O	1514	1515	)	)	)	O
O	1515	1516	.	.	.	O

O	1517	1527	CONCLUSION	CONCLUSION	NN	B-NP
O	1527	1528	:	:	:	O
O	1529	1533	Down	Down	NN	B-NP
O	1533	1534	-	-	HYPH	O
O	1534	1543	regulated	regulate	VBN	B-VP
O	1544	1554	expression	expression	NN	B-NP
O	1555	1557	of	of	IN	B-PP
O	1558	1562	PTEN	PTEN	NN	B-NP
O	1563	1567	gene	gene	NN	I-NP
O	1568	1570	is	be	VBZ	B-VP
O	1571	1576	found	find	VBN	I-VP
O	1577	1579	in	in	IN	B-PP
O	1580	1589	different	different	JJ	B-NP
O	1590	1596	stages	stage	NNS	I-NP
O	1597	1599	of	of	IN	B-PP
B-Cancer	1600	1607	gastric	gastric	JJ	B-NP
I-Cancer	1608	1617	carcinoma	carcinoma	NN	I-NP
O	1617	1618	,	,	,	O
O	1619	1622	and	and	CC	O
O	1623	1625	is	be	VBZ	B-VP
O	1626	1633	closely	closely	RB	I-VP
O	1634	1644	correlated	correlate	VBN	I-VP
O	1645	1649	with	with	IN	B-PP
O	1650	1653	LOH	LOH	NN	B-NP
O	1654	1656	of	of	IN	B-PP
O	1657	1660	its	its	PRP$	B-NP
O	1661	1671	epigenetic	epigenetic	JJ	I-NP
O	1672	1687	microsatellites	microsatellite	NNS	I-NP
O	1687	1688	,	,	,	O
O	1689	1694	which	which	WDT	B-NP
O	1695	1703	probably	probably	RB	B-ADVP
O	1704	1706	is	be	VBZ	B-VP
O	1707	1710	its	its	PRP$	B-NP
O	1711	1721	underlying	underlie	VBG	I-NP
O	1722	1731	molecular	molecular	JJ	I-NP
O	1732	1742	mechanisms	mechanism	NNS	I-NP
O	1742	1743	.	.	.	O

O	1744	1746	It	It	PRP	B-NP
O	1747	1755	suggests	suggest	VBZ	B-VP
O	1756	1760	that	that	IN	B-SBAR
O	1761	1768	altered	alter	VBN	B-NP
O	1769	1773	PTEN	PTEN	NN	I-NP
O	1774	1778	gene	gene	NN	I-NP
O	1779	1790	contributes	contribute	VBZ	B-VP
O	1791	1793	to	to	TO	B-PP
O	1794	1807	tumorigenesis	tumorigenesis	NN	B-NP
O	1808	1811	and	and	CC	I-NP
O	1812	1823	progression	progression	NN	I-NP
O	1824	1826	of	of	IN	B-PP
B-Cancer	1827	1834	gastric	gastric	JJ	B-NP
I-Cancer	1835	1845	carcinomas	carcinoma	NNS	I-NP
O	1845	1846	.	.	.	O

